IRIS
SONCINI, DEBORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.760
AS - Asia 762
NA - Nord America 678
Continente sconosciuto - Info sul continente non disponibili 120
SA - Sud America 57
AF - Africa 12
Totale 7.389
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.626
US - Stati Uniti d'America 629
SG - Singapore 271
CN - Cina 162
VN - Vietnam 137
BD - Bangladesh 122
FR - Francia 43
BR - Brasile 33
HK - Hong Kong 28
CA - Canada 24
DE - Germania 22
GB - Regno Unito 13
FI - Finlandia 12
MX - Messico 11
AR - Argentina 10
IN - India 9
IQ - Iraq 8
JP - Giappone 7
CH - Svizzera 6
SE - Svezia 6
UA - Ucraina 6
EC - Ecuador 5
NL - Olanda 5
PY - Paraguay 5
HN - Honduras 4
IE - Irlanda 4
AT - Austria 3
ID - Indonesia 3
LT - Lituania 3
TR - Turchia 3
ZA - Sudafrica 3
AL - Albania 2
BE - Belgio 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
JM - Giamaica 2
MA - Marocco 2
PA - Panama 2
SA - Arabia Saudita 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BZ - Belize 1
CO - Colombia 1
GA - Gabon 1
GP - Guadalupe 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
MD - Moldavia 1
MG - Madagascar 1
MT - Malta 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 7.269
Salva come PNG Salva come JPEG
Città #
Genova 2.844
Genoa 1.825
Rapallo 497
Vado Ligure 329
Singapore 133
San Jose 126
Ashburn 79
Ho Chi Minh City 50
Lauterbourg 39
Beijing 35
New York 32
Hanoi 30
Hong Kong 27
Los Angeles 24
Frankfurt am Main 18
Council Bluffs 17
Milan 15
Santa Clara 15
Rome 14
Buffalo 10
Da Nang 9
Helsinki 9
Schiavon 9
Chicago 8
Bordighera 7
Mexico City 7
Boardman 6
Brooklyn 6
Houston 6
Montreal 6
Phoenix 6
São Paulo 6
Tokyo 6
Zurich 6
Bologna 5
Dallas 5
Mumbai 5
Orem 5
Parma 5
Turin 5
Baghdad 4
Can Tho 4
City of London 4
Kyiv 4
Naples 4
Newark 4
Springfield 4
Amsterdam 3
Buenos Aires 3
Cardiff 3
Charlotte 3
Djursholm 3
Dublin 3
Florence 3
Haiphong 3
Hải Dương 3
Lappeenranta 3
Manchester 3
Miami 3
Milwaukee 3
Palermo 3
Philadelphia 3
Phủ Lý 3
Piscataway 3
Quito 3
Seattle 3
Stockholm 3
The Dalles 3
Tianjin 3
Toronto 3
Westminster 3
Albany 2
Alexandria 2
Algiers 2
Asunción 2
Biên Hòa 2
Canton 2
Chesapeake 2
Ciudad del Este 2
Cuenca 2
Detroit 2
Endicott 2
Erie 2
Harrisonburg 2
Hewitt 2
Ilion 2
Jersey City 2
Lawrenceville 2
Meriden 2
Midlothian 2
Nha Trang 2
Nuremberg 2
Omaha 2
Oxnard 2
Panama City 2
Paris 2
Ponte dell'Olio 2
Poplar 2
Porto Alegre 2
Potenza 2
Totale 6.444
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 326
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 262
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 252
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 250
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 248
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 226
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 207
Ras-induced resistance to lapatinib is overcome by MEK inhibition 206
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects 206
Fasting potentiates the anticancer activity of tyrosin kinase inhibitors by strenghtening MAPK signalling inhibition. 197
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. 195
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 191
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition 187
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 186
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments. Concordance with experimental results. 185
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 180
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 179
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 177
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 176
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 176
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. 171
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status 170
Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies 166
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 163
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death 161
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 155
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 154
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 151
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 146
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice. 144
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. 141
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 141
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment 135
SIRT6 inhibition as a novel approach for treating Acute Myeloid Leukemia 133
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 116
Synergistic Interaction Between P-glycoprotein Inhibitors and APO866 in Primary Leukemic Cells 112
CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma 109
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies 103
Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis 100
Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells 95
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 78
EXTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) ARRESTS ENDOTHELIAL CELL PROLIFERATION 78
Higher CD56 Expression on Multiple Myeloma Cells Increases CD38 Expression, Reduces Intracellular NAD+ Levels, and Enhances the Efficacy of Daratumumab-Based Treatment Strategies 67
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1 57
The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLS 52
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 45
Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma 24
Severe hypereosinophilia and eosinophilic myocarditis during secondary plasma cell leukemia: evidence of a paraneoplastic manifestation of aggressive myeloma evolution. 10
Totale 7.389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.657
article - articoli 22.089
book - libri 0
conference - conferenze 568
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022466 15 21 35 74 18 36 22 97 20 39 28 61
2022/2023603 55 59 10 92 101 72 8 43 83 9 63 8
2023/2024358 10 28 15 52 34 78 14 45 13 3 15 51
2024/20251.102 37 61 16 81 102 104 91 219 41 73 133 144
2025/20262.205 265 81 141 198 282 143 251 106 161 194 212 171
2026/2027197 197 0 0 0 0 0 0 0 0 0 0 0
Totale 7.389